Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study-Reference-Cited by-同舟云学术

Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

Published:2016-03-25 Issue:3 Volume:156 Page:465-472
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

van Roozendaal Lori M.^ORCID,Smit Leonie H. M.,Duijsens Gaston H. N. M.,de Vries Bart,Siesling Sabine,Lobbes Marc B. I.,de Boer Maaike,de Wilt Johannes H. W.,Smidt Marjolein L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3757-4.pdf

Reference34 articles.

1. Abdulkarim BS, Cuartero J, Hanson J, Deschenes J, Lesniak D, Sabri S (2011) Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol 29(21):2852–2858. doi: 10.1200/JCO.2010.33.4714

2. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429–4434. doi: 10.1158/1078-0432.CCR-06-3045

3. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24(36):5652–5657. doi: 10.1200/JCO.2006.06.5664

4. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502. doi: 10.1001/jama.295.21.2492

5. Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA (2015) The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Ann Surg Oncol 22(3):874–882. doi: 10.1245/s10434-014-4279-0

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Outcomes after Postoperative Radiotherapy in Triple-Negative Breast Cancer: Multi-Institutional Retrospective Study (KROG 17-05);Journal of Personalized Medicine;2024-09-04

2. Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy;Frontiers in Cell and Developmental Biology;2024-09-02

3. Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database;Annals of Surgical Oncology;2024-06-13

4. Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer;Breast Cancer Research and Treatment;2024-04-30

5. Metabolomics and triple-negative breast cancer: A systematic review;Heliyon;2024-01